Gullimex attracts investor Holland Capital for further growth
Borne / Amsterdam, 10th of March 2025 – Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.
Growing quality standards
The importance of food safety, patient safety, and hygiene continues to grow in a market characterized by increasingly stringent regulations and rising expectations regarding quality and efficiency. Gullimex supports businesses and institutions in navigating this dynamic and demanding environment, optimizing their processes through its role as an advisor, premium brand supplier, and service partner.
Gullimex ensures consistent quality measurements, optimal hygiene, and safe production within mission-critical processes. The company achieves this through an integrated combination of hardware, software, and services, providing customers with solutions that directly address the specific needs and challenges of the food and medical sectors.
Investment for growth
Gullimex aims to become the leading European provider of measurement, quality, and control solutions, leveraging data to create value for the food and medical industries. With Holland Capital’s investment, the company can achieve its growth ambitions both organically and through strategic acquisitions.
Maarten Snijders, Investment Director AgriFood-Tech at Holland Capital, said: “We are proud to support Gullimex in achieving its ambitions. As an investor with years of experience in Tech, AgriFood, and Healthcare, we aim to contribute to Gullimex’s international growth and its mission to create even more value for all its partners.”
Lucien Kwakkel, CEO of Gullimex, added: “We value Holland Capital as a strategic partner that not only invests in our growth but also actively supports us with expertise, experience, a strong network, and a hands-on mentality. Thanks to their experience and vision, we can further strengthen our position in key markets and accelerate our ambitions both nationally and internationally.”
About Gullimex
Founded in 1981, Gullimex supports a large customer base within the food and medical sectors with measurement and data recording solutions. The team of 60+ experts is active in the fields of food safety, patient safety, and hygiene. Gullimex has offices in the Netherlands, Belgium, and Germany.
About Holland Capital
For over 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the common goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With its specialized sector teams, the firm focuses on Healthcare, Technology, and AgriFood-Tech. It understands the dynamics and opportunities within these sectors and has an extensive network.
Holland Capital looks back on a positive 2025
This year again, Holland Capital has taken important steps within the Technology and Healthcare sectors. Our clear investment strategy, combined with close and active collaboration with entrepreneurs and advisors, has resulted in the further expansion of our portfolio and strong progress within our Holland Capital Growth & Buy-Out Fund V.
Adjust expands advisory proposition with acquisition of Accent Advies
Our portfolio company Adjust Consulting (Adjust) is expanding its advisory proposition with the acquisition of Accent Advies.
Emixa acquires Nextage Group to further strengthen its presence and focus on Digital Thread leadership in the Nordics
Our portfolio company Emixa, a leading European digital transformation consultancy and trusted partner for Siemens, SAP, Mendix and integration technologies, today announced the acquisition of Nextage Group, one of the most respected Siemens Digital Industries Software partners in the Nordic region.
Semalytix Secures €5.7 Million to Scale its Agentic AI Platform
Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its €5.7 million growth round.
HMCC Completes Add-On Investment in CareAbout
Our portfolio company HMCC proudly announces the successful completion of an add-on investment in CareAbout. This step brings together two strong organizations, joining forces to further support healthcare providers in ensuring continuity of care.
Abilia acquires portfolio company LivAssured
Abilia, a subsidiary of MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire Holland Capital’s portfolio company LivAssured B.V.
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl





